151 3D lung models – 3D extracellular matrix models REFERENCES 1. Frantz C, Stewart KM, Weaver VM. The extracellular matrix at a glance. J Cell Sci 2010: 123(Pt 24): 4195-4200. 2. Jarvelainen H, Sainio A, Koulu M, Wight TN, Penttinen R. Extracellular matrix molecules: potential targets in pharmacotherapy. Pharmacol Rev 2009: 61(2): 198-223. 3. Daley WP, Peters SB, Larsen M. Extracellular matrix dynamics in development and regenerative medicine. J Cell Sci 2008: 121(Pt 3): 255-264. 4. Matthes SA, Hadley R, Roman J, White ES. Comparative Biology of the Normal Lung Extracellular Matrix. In: Parent RA, ed. Comparative Biology of the Normal Lung. Academic Press, San Diego, 2015; pp. 387-402. 5. White ES. Lung extracellular matrix and fibroblast function. Ann Am Thorac Soc 2015: 12 Suppl 1(Suppl 1): S30-33. 6. Upagupta C, Shimbori C, Alsilmi R, Kolb M. Matrix abnormalities in pulmonary fibrosis. Eur Respir Rev 2018: 27(148): 180033. 7. McGowan SE. Extracellular matrix and the regulation of lung development and repair. FASEB J 1992: 6(11): 2895-2904. 8. Zhou Y, Horowitz JC, Naba A, Ambalavanan N, Atabai K, Balestrini J, Bitterman PB, Corley RA, Ding BS, Engler AJ, Hansen KC, Hagood JS, Kheradmand F, Lin QS, Neptune E, Niklason L, Ortiz LA, Parks WC, Tschumperlin DJ, White ES, Chapman HA, Thannickal VJ. Extracellular matrix in lung development, homeostasis and disease. Matrix Biol 2018: 73: 77-104. 9. Brandsma CA, Van den Berge M, Hackett TL, Brusselle G, Timens W. Recent advances in chronic obstructive pulmonary disease pathogenesis: from disease mechanisms to precision medicine. J Pathol 2020: 250(5): 624-635. 10. Theocharis AD, Skandalis SS, Gialeli C, Karamanos NK. Extracellular matrix structure. Adv Drug Deliv Rev 2016: 97: 4-27. 11. Mecham RP. Elastin in lung development and disease pathogenesis. Matrix Biol 2018: 73: 6-20. 12. Starcher BC. Lung elastin and matrix. Chest 2000: 117(5 Suppl 1): 229S-234S. 13. Joyce K, Fabra GT, Bozkurt Y, Pandit A. Bioactive potential of natural biomaterials: identification, retention and assessment of biological properties. Signal Transduct 2021: 6(1): 122. 14. Souza-Fernandes AB, Pelosi P, Rocco PR. Bench-to-bedside review: the role of glycosaminoglycans in respiratory disease. Crit Care 2006: 10(6): 237. 15. Karakioulaki M, Papakonstantinou E, Stolz D. Extracellular matrix remodelling in COPD. Eur Respir Rev 2020: 29(158): 190124. 16. Garg HG. Proteoglycans in Lung Disease. CRC Press, 2002. 17. Couchman JR, Pataki CA. An introduction to proteoglycans and their localization. J Histochem Cytochem 2012: 60(12): 885-897. 18. Xu J, Mosher D. Fibronectin and Other Adhesive Glycoproteins. In: Mecham RP, ed. The Extracellular Matrix: an Overview. Springer Berlin Heidelberg, Berlin, Heidelberg, 2011; pp. 41-75. 6
RkJQdWJsaXNoZXIy MTk4NDMw